RT Book, Section A1 Jain, Nitin A1 Bueso-Ramos, Carlos A1 O'Brien, Susan A1 Wierda, William G. A2 Kantarjian, Hagop M. A2 Wolff, Robert A. SR Print(0) ID 1126739896 T1 Chronic Lymphocytic Leukemia and Associated Disorders T2 The MD Anderson Manual of Medical Oncology, 3e YR 2016 FD 2016 PB McGraw-Hill Medical PP New York, NY SN 9780071847940 LK hemonc.mhmedical.com/content.aspx?aid=1126739896 RD 2024/03/28 AB Chronic lymphocytic leukemia (CLL) is a clonal hematopoietic disorder involving expansion of CD5-positive B cells. Chemoimmunotherapy (CIT) has been the standard first-line treatment for patients with CLL (1). In the last several years, major strides have been made in understanding the disease biology of CLL, and, fortunately, several of these discoveries are making their way into the clinic.